Clinical Care for People Who Survive Childhood Cancer: A Review
- PMID: 37750876
- DOI: 10.1001/jama.2023.16875
Clinical Care for People Who Survive Childhood Cancer: A Review
Abstract
Importance: An estimated 15 000 children and adolescents aged 0 to 19 years are diagnosed with cancer each year in the US, and more than 85% survive for at least 5 years. By 45 years of age, approximately 95% of people who survive childhood cancer will develop a significant health problem related to the childhood cancer diagnosis or its treatment.
Observations: Approximately 500 000 people currently alive in the US have survived childhood cancer. The most common severe or life-threatening chronic health problems related to childhood cancer or its treatment are endocrine disorders such as hypothyroidism or growth hormone deficiency (44%), subsequent neoplasms such as breast cancer or thyroid cancer (7%), and cardiovascular disease such as cardiomyopathy or congestive heart failure, coronary artery disease, and cerebrovascular disease (5.3%). Medical conditions related to a cancer diagnosis during childhood or adolescence are most commonly caused by the radiation therapy and the chemotherapies used to treat cancer and may develop at varying lengths of time after exposure to these treatments. Individuals at highest risk for developing treatment-related health problems include patients with brain cancer treated with cranial irradiation (approximately 70% develop severe or life-threatening health problems) and allogeneic hematopoietic stem cell transplant recipients (approximately 60% develop severe or life-threatening health problems). Individuals at the lowest risk for developing treatment-related health problems include those who survived solid tumors (such as Wilms tumor) treated with surgical resection alone or with minimal chemotherapy, for whom the prevalence of subsequent health problems is similar to people who did not have cancer during childhood or adolescence. People diagnosed with childhood cancer in the 1990s who survived for at least 5 years after the cancer diagnosis have a shorter lifespan (by about 9 years) vs children who were not diagnosed with cancer in the 1990s.
Conclusions and relevance: Approximately 500 000 individuals currently alive in the US have survived childhood cancer. The most common adverse effects in individuals who survived childhood cancer are endocrine disorders, subsequent neoplasms, and cardiovascular disease. There is a need for clinicians and patients to have heightened awareness of these complications.
Comment in
-
Survival of Childhood Cancer and Subsequent Clinical Care.JAMA. 2024 Feb 20;331(7):616-617. doi: 10.1001/jama.2023.26987. JAMA. 2024. PMID: 38497702 No abstract available.
Similar articles
-
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.Lancet Oncol. 2018 Dec;19(12):1590-1601. doi: 10.1016/S1470-2045(18)30537-0. Epub 2018 Nov 8. Lancet Oncol. 2018. PMID: 30416076 Free PMC article.
-
DIAGNOSING AND MONITORING ENDOCRINE DYSFUNCTION, DIABETES, AND OBESITY IN A COHORT OF ADULT SURVIVORS OF CHILDHOOD CANCER.Endocr Pract. 2017 Dec;23(12):1394-1401. doi: 10.4158/EP-2017-0033. Epub 2017 Nov 16. Endocr Pract. 2017. PMID: 29144813
-
Late endocrine effects of childhood cancer.Nat Rev Endocrinol. 2016 Jun;12(6):319-36. doi: 10.1038/nrendo.2016.45. Epub 2016 Apr 1. Nat Rev Endocrinol. 2016. PMID: 27032982 Review.
-
Approaches to reduce the long-term burden of treatment-related complications in survivors of childhood cancer.Am Soc Clin Oncol Educ Book. 2015:196-204. doi: 10.14694/EdBook_AM.2015.35.196. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993157 Review.
-
Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.Cancer. 2003 Feb 1;97(3):663-73. doi: 10.1002/cncr.11095. Cancer. 2003. PMID: 12548609
Cited by
-
Commentary on "Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescents".Ann Pediatr Endocrinol Metab. 2024 Apr;29(2):73-74. doi: 10.6065/apem.2423023edi02. Epub 2024 Apr 30. Ann Pediatr Endocrinol Metab. 2024. PMID: 38712490 Free PMC article. No abstract available.
-
Oral microbiome characteristics in patients with pediatric solid tumor.Front Microbiol. 2024 Jan 5;14:1286522. doi: 10.3389/fmicb.2023.1286522. eCollection 2023. Front Microbiol. 2024. PMID: 38249475 Free PMC article.
-
Late health outcomes among survivors of Wilms tumor.Transl Pediatr. 2023 Nov 28;12(11):1941-1943. doi: 10.21037/tp-23-428. Epub 2023 Oct 20. Transl Pediatr. 2023. PMID: 38130593 Free PMC article. No abstract available.
-
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients.Rev Endocr Metab Disord. 2024 Jun;25(3):555-573. doi: 10.1007/s11154-023-09868-4. Epub 2023 Dec 19. Rev Endocr Metab Disord. 2024. PMID: 38112850 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical